过去一年中添加的文章，按日期排序
[PDF][PDF] The mechanistic modes of Targeting immunometabolism in cancer: An innovative strategy: A narrative review
KK Kaur, GN Allahbadia - 2024 - researchgate.net
14 天前 - … ),breast cancer(BC), Hepatocellular carcinoma(HCC), non … for NSCLC, PI3K/
AKT/mTOR signaling in T2DM treatment … cancer (NSCLC),by targeting mucin, PI3K/ AKT/mTOR …
AKT/mTOR signaling in T2DM treatment … cancer (NSCLC),by targeting mucin, PI3K/ AKT/mTOR …
Molecular Targets of Plant-based Alkaloids and Polyphenolics in Liver and Breast Cancer-An Insight into Anticancer Drug Development
S Batool, L Asim, FR Qureshi, A Masood… - Anti-cancer agents in … - pubmed.ncbi.nlm.nih.gov
17 天前 - … in liver and breast cancer cells by activating … signaling pathways, such as PI3K/AKT/mTOR,
STAT3, NF-kB, Shh, MAPK/ERK, and Wnt/β-catenin pathways, to control cancer cell …
STAT3, NF-kB, Shh, MAPK/ERK, and Wnt/β-catenin pathways, to control cancer cell …
[HTML][HTML] Exploring the Anti-Cancer Properties of Azadirachta indica: In Silico and In Vitro Study of Its Phytochemicals against Hepatocellular Carcinoma
H Khalid, S Shityakov, CY Förster, Y Song - Journal of Molecular Structure, 2024 - Elsevier
31 天前 - … to examine the role of the PI3K/Akt/mTOR pathway in the pathogenesis of HCC. Akt1,
a … target of the rapamycin signaling pathway and is upregulated in various types of cancer […
a … target of the rapamycin signaling pathway and is upregulated in various types of cancer […
Unveiling the role of UPF3B in hepatocellular carcinoma: Potential therapeutic target
B Hou, M Shu, C Liu, Y Du, C Xu, H Jiang… - Cancer …, 2024 - Wiley Online Library
32 天前 - … HCC growth through the PI3K/AKT/mTOR pathway. Hence, it could be a promising
therapeutic target for treating HCC. … the PI3K/ AKT/mTOR signaling to promote HCC growth. …
therapeutic target for treating HCC. … the PI3K/ AKT/mTOR signaling to promote HCC growth. …
AURKB targets DHX9 to promote hepatocellular carcinoma progression via PI3K/AKT/mTOR pathway
G Zhu, L Luo, Y He, Y Xiao, Z Cai… - Molecular …, 2024 - Wiley Online Library
36 天前 - … in liver cancer is unknown. This study aimed to investigate the role of AURKB in
hepatocellular carcinoma (HCC) … was significantly overexpressed in HCC tissues and cell lines, …
hepatocellular carcinoma (HCC) … was significantly overexpressed in HCC tissues and cell lines, …
Role of PI3K-AKT-mTOR signaling pathway-related circular RNAs in the diagnosis and prognosis of hepatocellular carcinoma: a systematic review and meta-analysis
S Wang, M Wu, B Xie, Y Tian, X Ma, J Li, B Ma, L Li - 2024 - researchsquare.com
40 天前 - … HCC patients and explored the role of circRNAs in HCC patients in diverse aspects.
Third, we targeted PI3K/AKT/mTOR pathway-… are more closely related to HCC for a clearer …
Third, we targeted PI3K/AKT/mTOR pathway-… are more closely related to HCC for a clearer …
[HTML][HTML] Integrated Bioinformatic Analysis Reveals the Oncogenic, Survival, and Prognostic Characteristics of TPX2 in Hepatocellular Carcinoma
W Zhang, J Dong, Y Wu, X Liang, L Suo, L Wang - Biochemical Genetics, 2024 - Springer
46 天前 - … This study investigated the role of TPX2 in hepatocellular carcinoma (HCC… pathway
vital in regulating the cell cycle (Tewari et al. 2022). Targeting the PI3K/AKT/mTOR pathway …
vital in regulating the cell cycle (Tewari et al. 2022). Targeting the PI3K/AKT/mTOR pathway …
FAT10 induces immune suppression by upregulating PD-L1 expression in hepatocellular carcinoma
Q Wang, W Tan, Z Zhang, Q Chen, Z Xie, L Yang… - Apoptosis, 2024 - Springer
48 天前 - … upregulates PD-L1 expression via PI3K/AKT/mTOR signaling. Collectively, the
above … as a novel target for improving the efficacy of cancer immunotherapy in HCC patients. …
above … as a novel target for improving the efficacy of cancer immunotherapy in HCC patients. …
The Complex Connection between Obesity and Cancer: Signaling Pathways and Therapeutic Implications
52 天前 - … that greatly enhance the likelihood of hepatocellular carcinoma. Oxidative stress and
the … PI3K/AKT/mTOR pathway is a crucial mechanism linked to the development of cancer (…
the … PI3K/AKT/mTOR pathway is a crucial mechanism linked to the development of cancer (…
Bone mesenchymal stem cells improve cholestatic liver fibrosis by targeting ULK1 to regulate autophagy through PI3K/AKT/mTOR pathway
T Huang, C Zhang, Z Shang, Q Shuai… - Stem Cells …, 2024 - academic.oup.com
68 天前 - … signaling pathways, such as PI3K/AKT/mTOR. To clarify whether BMSCs inhibited
autophagy in HSCs by activating the PI3K/AKT/mTOR pathway… upregulating PI3K/AKT/mTOR. …
autophagy in HSCs by activating the PI3K/AKT/mTOR pathway… upregulating PI3K/AKT/mTOR. …